TNFAIP6 and metabolic dysfunction-associated steatotic liver disease: As shown in Fig. 4D, key processes related to inflammatory damage and repair, such as Metabolic pathways, Chemical carcinogenesis-reactive oxygen species, Thermogenesis, Non − alcoholic fatty liver disease, and Neutrophil extracellular trap formation (NET), were closely associated with TSG-6 therapy.